Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

March 31, 2020

Study Completion Date

August 1, 2020

Conditions
Cesarean Section Complications
Interventions
DRUG

Carbetocin

Group (A): included 100 patients who received carbetocin 100 µg diluted in 10 ml normal saline and administered slowly (over 30-60 seconds) intravenously by anesthetist after the birth of the baby.

DRUG

oxytocin

Group (B): included 100 patients who received a combination of intraoperative oxytocin 5 I.U which was diluted in 10 ml normal saline and administered slowly over (30-60 seconds) intravenously by anesthetist and

DRUG

ergometrine

intramuscular ergometrine 0.2 mg.

Trial Locations (1)

81528

AswanUH, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT03578263 - Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage | Biotech Hunter | Biotech Hunter